Thomas J. Smith

Thomas J. Smith is a Senior Research Analyst at Leerink Partners covering Immunology and Metabolism.

Prior to joining the Firm in 2018, Mr. Smith was a Vice President and Research Analyst at Morgan Stanley, where he covered leading and emerging biopharmaceutical companies across multiple therapeutic areas, including oncology, NASH, and women’s health. Prior to Morgan Stanley, Mr. Smith worked at FBR Capital Markets on the biotechnology team, covering large-, mid-, and small-cap companies. Mr. Smith began his career at Bloomberg, where he held roles of increasing responsibility, including coverage of biotech and specialty pharmaceutical sectors for Bloomberg Intelligence. Prior to covering Immunology and Metabolism, Mr. Smith was a key member of the Firm’s Targeted Oncology team.

Mr. Smith earned a B.S. in Finance and Psychology from The College of New Jersey.